Clinical Trial Update: Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating sequences of dasatinib or nilotinib followed by imatinib in newly diagnosed chronic phase chronic myeloid leukemia; study terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Myelogenous Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)
• Imatinib (imatinib)
• Nilotinib (nilotinib)

Snippet

Sponsor: Emory University | Conditions: Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2018-11-02